ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,202Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 783

$815K Total Retail Price of All Prescriptions

Rank: 91 out of 783

400 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 14,474 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 820 733 1 7
POTASSIUM CHLORIDE 709 589 2 16
SIMVASTATIN 683 535 3 3
WARFARIN SODIUM 609 428 4 10
LEVOTHYROXINE SODIUM 602 472 5 1
LISINOPRIL 521 419 6 4
HYDROCODONE-ACETAMINOPHEN 420 280 S3 7 2
DONEPEZIL HCL 419 419 8 24
OMEPRAZOLE 409 376 9 6
AMLODIPINE BESYLATE 359 322 10 5
GABAPENTIN 305 225 11 15
METOPROLOL TARTRATE 254 211 12 9
DIGOXIN 248 208 13 61
NAMENDA 229 229 14 32
HYDROCHLOROTHIAZIDE 198 123 15 12
SERTRALINE HCL 190 161 16 22
CITALOPRAM HBR 179 146 17 19
NYSTATIN 177 163 18 106
DIVALPROEX SODIUM 174 153 19 72
CARVEDILOL 171 130 20 21
POLYETHYLENE GLYCOL 3350 153 135 21 43
CLOPIDOGREL 150 128 22 29
ESCITALOPRAM OXALATE 148 127 23 54
LIDODERM 147 147 24 132
TRAMADOL HCL 144 106 25 20
OXYBUTYNIN CHLORIDE 142 121 26 96
METFORMIN HCL 142 92 26 8
QUETIAPINE FUMARATE 142 130 26 79
PANTOPRAZOLE SODIUM 138 96 29 30
NIFEDIPINE ER 138 95 29 135
ENALAPRIL MALEATE 137 137 31 68
TRAZODONE HCL 136 109 32 39
ACETAMINOPHEN-CODEINE 134 109 S3 33 144
METOPROLOL SUCCINATE 134 112 33 13
IBUPROFEN 131 64 35 115
ALLOPURINOL 131 116 35 31
FAMOTIDINE 130 105 37 55
PROAIR HFA 126 70 38 56
EXELON 118 118 39 109
PLAVIX 112 97 40 51
ISOSORBIDE MONONITRATE ER 110 96 41 40
AZITHROMYCIN 108 84 42 41
SPIRONOLACTONE 105 66 43 57
IPRATROPIUM-ALBUTEROL 102 98 44 110
RISPERIDONE 101 101 45 67
ADVAIR DISKUS 101 60 45 50
AMITRIPTYLINE HCL 98 41 R 47 77
ALBUTEROL SULFATE 95 92 48 136
RANITIDINE HCL 95 59 48 44
ZOLPIDEM TARTRATE 93 87 50 23
VENLAFAXINE HCL ER 91 65 51 100
CYMBALTA 90 58 52 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 67 53 33
ATORVASTATIN CALCIUM 88 61 54 11
TAMSULOSIN HCL 86 60 55 26
NEXIUM 77 35 56 28
MELOXICAM 77 66 56 37
SSD 76 62 58 292
LEVOFLOXACIN 76 63 58 75
VENTOLIN HFA 74 11 60 159
FENTANYL 72 64 S2 61 65
PHENYTOIN SODIUM EXTENDED 71 59 62 141
ISOSORBIDE DINITRATE 67 67 63 243
OXYBUTYNIN CHLORIDE ER 66 55 64 117
LANTUS 65 65 65 38
LYRICA 65 41 65 98
GLIPIZIDE 65 50 65 71
LEXAPRO 65 61 65 181
PREDNISONE 64 53 69 36
ATENOLOL 64 63 69 17
CLONIDINE HCL 64 58 69 60
ALENDRONATE SODIUM 63 62 72 25
PROMETHAZINE HCL 61 26 R 73 97
FLOVENT HFA 60 28 74 288
LEVETIRACETAM 60 46 74 89
NITROFURANTOIN MONO-MACRO 60 54 74 174
PHENYTOIN 58 0 77 421
CARBIDOPA-LEVODOPA 57 57 78 88
CIPROFLOXACIN HCL 57 48 78 62
VENLAFAXINE HCL 53 53 80 233
HYDRALAZINE HCL 52 43 81 78
MEGESTROL ACETATE 52 31 R 81 238
NOVOLIN R 51 51 83 185
ZETIA 51 43 83 80
CYCLOBENZAPRINE HCL 51 33 R 83 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.